Evidence map›Paper›PMID 37520467›Full record

ArticleMolecular biology research communications2023

Association between

Ahlem Messal, Ghania Abid, Meriem Abdi, Aicha Idder, Naima Meroufel, Faouzia Zemani-Fodil, Mostefa Fodil

Open access · greenAbstract read
In one paragraph

Article in Molecular biology research communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Genetic polymorphisms in human CXJournal of neuroinflammation · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Ahlem MessalLaboratory of molecular and cellular biology, Université des Sciences et de la Technologie d'Oran Mohamed Boudiaf, USTO-MB, Oran, Algeria.
Ghania AbidLaboratory of molecular and cellular biology, Université des Sciences et de la Technologie d'Oran Mohamed Boudiaf, USTO-MB, Oran, Algeria.
Meriem AbdiLaboratory of molecular and cellular biology, Université des Sciences et de la Technologie d'Oran Mohamed Boudiaf, USTO-MB, Oran, Algeria.
Aicha IdderThematic Agency for Research in Health Sciences ATRSS, Algeria.
Naima MeroufelLaboratory of molecular and cellular biology, Université des Sciences et de la Technologie d'Oran Mohamed Boudiaf, USTO-MB, Oran, Algeria.
Faouzia Zemani-FodilLaboratory of molecular and cellular biology, Université des Sciences et de la Technologie d'Oran Mohamed Boudiaf, USTO-MB, Oran, Algeria.
Mostefa FodilBiOSSE (Biology of Organisms: Stress, Health, Environment), Le Mans University, F-72085 Le Mans, France.
Université des Sciences et de la Technologie d'Oran Mohamed Boudiaf · DZCentre Hospitalier du Mans · FRPublic Health Agency · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neovascular age-related macular degeneration (nAMD) is a progressive ocular disease, responsible for central visual loss and blindness in elderly population. Increase data demonstrate that genetic factors play an important role in pathogenesis process of this disease. The aim of this study is to investigate the association between rs3732378 polymorphism in

Indexed as

Algerian populationCX3CR1Neovascular age-related macular degenerationpolymorphism

Identifiers

PMID37520467
PMCPMC10382904
OpenAlexW4385406570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.